Literature DB >> 19669078

Investigating the concurrent presence of HCV in serum, oral fluid and urine samples from chronic HCV patients in Faisalabad, Pakistan.

Muhammad Shafique1, Nasir Ahmad, Fazli R Awan, Tanveer Mustafa, Mujib Ullah, Javed A Qureshi.   

Abstract

Hepatitis C virus (HCV) is normally present in the blood of infected patients; however, it can also be present in some other body fluids. Therefore, in this study, a concurrent presence of HCV-RNA was investigated in oral fluid and urine of 80 Pakistani chronic HCV patients. HCV-RNA was detected in 31 (38.8%) oral fluid and 10 (12.5%) urine samples using RT-PCR in all 80 of the patients whose sera tested positive for HCV-RNA. From this study, it is concluded that, in addition to the blood, HCV RNA can also be found in oral secretions as well as urine of chronic HCV patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669078     DOI: 10.1007/s00705-009-0477-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI).

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia T Javed; Sana Gull; Humaira Kausar; Muhammad T Sarwar; Sultan Asad; Imran Shahid; Aleena Sumrin; Saba Khaliq; Shah Jahan; Asim Pervaiz; Sajida Hassan
Journal:  BMC Gastroenterol       Date:  2011-04-21       Impact factor: 3.067

Review 2.  Bacterial and viral pathogens in saliva: disease relationship and infectious risk.

Authors:  Jørgen Slots; Henrik Slots
Journal:  Periodontol 2000       Date:  2011-02       Impact factor: 7.589

3.  Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity.

Authors:  Francisca Sosa-Jurado; Verónica L Hernández-Galindo; Daniel Meléndez-Mena; Miguel A Mendoza-Torres; Fernando J Martínez-Arroniz; Verónica Vallejo-Ruiz; Julio Reyes-Leyva; Gerardo Santos-López
Journal:  BMC Infect Dis       Date:  2014-02-10       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.